Company Statement: Allergan to acquire SkinMedica
MLex Summary: Global specialty pharmaceutical company Allergan has agreed to acquire SkinMedica's topical-aesthetics skin-care for $350 million up-front and an additional $25 million contingent upon the acquired products achieving a specific...To view the full article, register now.
Already a subscriber? Click here to view full article